MOLOGEN is a biotechnology company specializing in the field of immunotherapies with unique technologies and active ingredients. The company focuses on oncology and serious infectious diseases.
Company (Alive / Active)
Phone: +49 (0) 30 84 17 88 - 0
Fabeckstr. 30
Berlin, 14195
Germany
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Combination comprising immunostimulatory oligonucleotides | Jun 26, 2019 | Mar 31, 2020 | Patent |
Combination comprising immunostimulatory oligonucleotides | Sep 09, 2016 | Nov 26, 2019 | Patent |
Covalently closed non-coding immunomodulatory dna construct | Feb 18, 2015 | May 07, 2019 | Patent |
Predictive biomarker for cancer therapy | May 15, 2014 | Jun 26, 2018 | Patent |
Multimer for immunostimulation | May 11, 2007 | Nov 22, 2016 | Patent |